☰
BioMarin Pharmaceutical Inc.’s experimental gene therapy, valoctocogene roxaparvovec, targeting severe hemophilia A in adults has reportedly met pre-specified clinical criteria to seek regulatory review in the U.S. and Europe. ....
The program will include drilling 49 holes using one diamond drill rig and two reverse circulation (RC) rigs. Vancouver-based Victory Metals Inc. has recently announced the launch of a 10,000-metre drilling program at its Iron Point Vanadi....
The trials were set to determine the Reprieve-Guided Diuretic Therapy system’s ability to achieve safe net volume reduction while alleviating related symptoms in ADHF patients. Reprieve Cardiovascular™, one of the leading medic....
It has reached the enrollment target of 30-35 patients that was determined when the OPTION study was started in December 2018 AzurRx BioPharma has recently confirmed that it has achieved its enrollment target of 30-35 patients in the ongoi....
Pharmaceutical major Eli Lilly has officially launched an inexpensive generic version of the insulin drug Humalog, reports of which made way to the headlines in March. If sources are to be believed, the launch has come on the heels of the o....
The trial is being conducted in patients with recurrent high-grade glioma An Independent Data Monitoring Committee recommended the study continue without modification Reports confirm that Tocagen Inc, a clinical-stage and cancer-selective....
The FDA approval was awarded to Solifenacin Succinate tablets’ abbreviated new drug application (ANDA). The pharmaceutical firm now holds a total of 94 ANDA approvals from the US health regulator. Alembic Pharmaceuticals Ltd., (A....
Faasos involves delivery-only restaurants and brands which helps it to save on real estate costs. The capital markets company Coatue Management will reportedly lead a $120 million funding round in food on demand company Rebel Foods, popula....
177Lu-PSMA-617 is an experimental radiopharmaceutical which comprises of a peptide. The clinical-stage drug development company Noxopharm has reportedly announced positive provisional results from the LuPIN study concerning the Veyonda dru....
QIAGEN has been bringing its extensive track record of commercially creating and marketing novel diagnostic tests to the collaboration. QIAGEN N.V. and Inovio Pharmaceuticals Inc. have reportedly announced that both the companies have....
